Literature DB >> 21816954

Dihydroxypentamethoxyflavone down-regulates constitutive and inducible signal transducers and activators of transcription-3 through the induction of tyrosine phosphatase SHP-1.

Kanokkarn Phromnoi1, Sahdeo Prasad, Subash C Gupta, Ramaswamy Kannappan, Simone Reuter, Pornngarm Limtrakul, Bharat B Aggarwal.   

Abstract

Because constitutive activation of signal transducers and activators of transcription-3 (STAT3) has been linked with cellular transformation, survival, proliferation, chemoresistance, and angiogenesis of various tumor cells, agents that can suppress STAT3 activation have potential as cancer therapeutics. In the present report, we identified a flavone from the leaves of a Thai plant, Gardenia obtusifolia, 5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone (PMF), that has the ability to inhibit STAT3 activation. PMF inhibited both constitutive and interleukin-6-inducible STAT3 activation in multiple myeloma (MM) cells, as indicated by suppression of STAT3 phosphorylation, nuclear translocation, DNA binding, and STAT3-regulated gene expression. The inhibition of STAT3 by PMF was reversible. We found that the activation of various kinases including Janus-like kinase (JAK)-1, JAK-2, c-Src, extracellular signal-regulated kinases 1 and 2, AKT, and epidermal growth factor receptor, implicated in STAT3 activation, were inhibited by the flavone. It is noteworthy that pervanadate suppressed the ability of PMF to inhibit the phosphorylation of STAT3, suggesting that protein tyrosine phosphatase was involved. PMF induced the expression of SHP-1 and was linked to the dephosphorylation of STAT3, because its deletion by small interfering RNA abolished the PMF-induced constitutive and inducible STAT3 inhibition. STAT3 inhibition led to the suppression of proteins involved in proliferation (cyclin D1 and c-myc), survival (survivin, Mcl-1, Bcl-xL, Bcl-2, and cIAP-2), and angiogenesis (vascular endothelial growth factor). Finally, PMF inhibited proliferation and induced apoptosis of MM cells. PMF also significantly potentiated the apoptotic effects of Velcade and thalidomide in MM cells. Overall, these results suggest that PMF is a novel blocker of STAT3 activation and thus may have potential in suppression of tumor cell proliferation and reversal of chemoresistance in MM cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816954      PMCID: PMC3198920          DOI: 10.1124/mol.111.073676

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.

Authors:  Steven J Schreiner; Anthony P Schiavone; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

2.  Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Galphao protein.

Authors:  P T Ram; C M Horvath; R Iyengar
Journal:  Science       Date:  2000-01-07       Impact factor: 47.728

3.  [Antimicrobial activity of some medicinal species from the Dakar markets].

Authors:  A Laurens; S Mboup; M Tignokpa; O Sylla; J Masquelier
Journal:  Pharmazie       Date:  1985-07       Impact factor: 1.267

4.  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.

Authors:  Marcin Kortylewski; Maciej Kujawski; Tianhong Wang; Sheng Wei; Shumin Zhang; Shari Pilon-Thomas; Guilian Niu; Heidi Kay; James Mulé; William G Kerr; Richard Jove; Drew Pardoll; Hua Yu
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

5.  In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.

Authors:  Manik Chatterjee; Dirk Hönemann; Suzanne Lentzsch; Kurt Bommert; Christine Sers; Pia Herrmann; Stephan Mathas; Bernd Dörken; Ralf C Bargou
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.

Authors:  Min-Hsiung Pan; Wei-Jen Chen; Shoei-Yn Lin-Shiau; Chi-Tang Ho; Jen-Kun Lin
Journal:  Carcinogenesis       Date:  2002-10       Impact factor: 4.944

7.  Reversal of P-glycoprotein-mediated multidrug resistance by 5,6,7,3',4'-pentamethoxyflavone (Sinensetin).

Authors:  Cheol Hee Choi; Kyung Hoon Sun; Chun San An; Jin Cheol Yoo; Kyung Soo Hahm; In Hwa Lee; Jae Kyung Sohng; Youn Chul Kim
Journal:  Biochem Biophys Res Commun       Date:  2002-07-26       Impact factor: 3.575

8.  Isolation of Campylobacter fetus subsp jejuni from zoo animals.

Authors:  N W Luechtefeld; R C Cambre; W L Wang
Journal:  J Am Vet Med Assoc       Date:  1981-12-01       Impact factor: 1.936

9.  Anti-HIV-1 cycloartanes from leaves and twigs of Gardenia thailandica.

Authors:  Patoomratana Tuchinda; Aroonchai Saiai; Manat Pohmakotr; Chalobon Yoosook; Jittra Kasisit; Chanita Napaswat; Thawatchai Santisuk; Vichai Reutrakul
Journal:  Planta Med       Date:  2004-04       Impact factor: 3.352

10.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.

Authors:  M Kawano; T Hirano; T Matsuda; T Taga; Y Horii; K Iwato; H Asaoku; B Tang; O Tanabe; H Tanaka
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

View more
  12 in total

Review 1.  IgE-dependent signaling as a therapeutic target for allergies.

Authors:  Donald W MacGlashan
Journal:  Trends Pharmacol Sci       Date:  2012-06-30       Impact factor: 14.819

Review 2.  Morquio A syndrome: diagnosis and current and future therapies.

Authors:  Shunji Tomatsu; Eriko Yasuda; Pravin Patel; Kristen Ruhnke; Tsutomu Shimada; William G Mackenzie; Robert Mason; Mihir M Thacker; Mary Theroux; Adriana M Montaño; Carlos J Alméciga-Díaz; Luis A Barrera; Yasutsugu Chinen; William S Sly; Daniel Rowan; Yasuyuki Suzuki; Tado Orii
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

3.  Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.

Authors:  Asma Beldi-Ferchiou; Nour Skouri; Cyrine Ben Ali; Ines Safra; Abderrahman Abdelkefi; Saloua Ladeb; Karima Mrad; Tarek Ben Othman; Mélika Ben Ahmed
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

4.  STAT3 and importins are novel mediators of early molecular and cellular responses in experimental duodenal ulceration.

Authors:  Tetyana Khomenko; Xiaoming Deng; Amrita Ahluwalia; Andrzej Tarnawski; Khushin N Patel; Zsuzsanna Sandor; Sandor Szabo
Journal:  Dig Dis Sci       Date:  2014-01-03       Impact factor: 3.199

Review 5.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

6.  SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma.

Authors:  Jung-Chen Su; Ping-Hui Tseng; Szu-Hsien Wu; Cheng-Yi Hsu; Wei-Tien Tai; Yong-Shi Li; I-Ting Chen; Chun-Yu Liu; Kuen-Feng Chen; Chung-Wai Shiau
Journal:  Neoplasia       Date:  2014-07-18       Impact factor: 5.715

7.  SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.

Authors:  Cong Li; Hong Li; Peng Zhang; Li-Jun Yu; Tian-Miao Huang; Xue Song; Qing-You Kong; Jian-Li Dong; Pei-Nan Li; Jia Liu
Journal:  Nutrients       Date:  2016-12-27       Impact factor: 5.717

8.  MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.

Authors:  Zi-Feng Zhang; Yong-Jian Wang; Shao-Hua Fan; Shi-Xin Du; Xue-Dong Li; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Oncotarget       Date:  2017-09-22

9.  A pentamethoxylated flavone from Glycosmis ovoidea promotes apoptosis through the intrinsic pathway and inhibits migration of MCF-7 breast cancer cells.

Authors:  Gerardo D Anaya-Eugenio; Peter J Blanco Carcache; Tran Ngoc Ninh; Yulin Ren; Djaja D Soejarto; A Douglas Kinghorn
Journal:  Phytother Res       Date:  2020-10-30       Impact factor: 5.878

10.  Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.

Authors:  Chun-Yu Liu; Ling-Ming Tseng; Jung-Chen Su; Kung-Chi Chang; Pei-Yi Chu; Wei-Tien Tai; Chung-Wai Shiau; Kuen-Feng Chen
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.